Skip to main content
Top
Published in: Journal of Cancer Survivorship 5/2023

05-01-2022 | Care

Importance of primary care for underserved cancer patients with multiple chronic conditions

Authors: Katelyn K. Jetelina, Simon Craddock Lee, Quiera S. Booker-Nubie, Udoka C. Obinwa, Hong Zhu, Michael E. Miller, Navid Sadeghi, Umber Dickerson, Bijal A. Balasubramanian

Published in: Journal of Cancer Survivorship | Issue 5/2023

Login to get access

Abstract

Purpose

To understand the impact of pre-existing conditions on healthcare utilization among under- and uninsured patients in the transition from cancer treatment to post-treatment survivorship.

Methods

Using electronic health record data, we constructed a cohort of patients seen in an integrated county health system between 1/1/2010 and 12/31/2016. Six hundred thirty-one adult patients diagnosed with non-metastatic breast or colorectal cancer during this period (cases) were matched 1:1 on sex and Charlson comorbidity index to non-cancer patients who had at least two chronic conditions and with at least one visit to the health system during the study period (controls). Conditional fixed effects Poisson regression models compared number of primary care and emergency department (ED) visits and completed [vs. no show or missed] appointments between cancer and non-cancer patients.

Results

Cancer patients had significantly lower number of visits compared with non-cancer patients (N = 46,965 vs. 85,038). Cancer patients were less likely to have primary care (IRR = 0.25; 95% CI: 0.24, 0.27) and ED visits (IRR = 0.57; 95% CI: 0.50, 0.64) but more likely to complete a scheduled appointment (AOR = 4.83; 95% CI: 4.32, 5.39) compared with non-cancer patients. Cancer patients seen in primary care at a higher rate were more likely to visit the ED (IRR = 2.06; 95% CI: 1.52, 2.80) than those seen in primary care at a lower rate.

Conclusion

Health systems need to find innovative, effective solutions to increase primary care utilization among cancer patients with chronic care conditions to ensure optimal management of both chronic conditions and cancer.

Implications for Cancer Survivors

Maintaining regular connections with primary care providers during active cancer treatment should be promoted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cho H, et al. Assessing non-cancer-related health status of us cancer patients: other-cause survival and comorbidity prevalence. Am J Epidemiol. 2013;178(3):339–49.CrossRefPubMedPubMedCentral Cho H, et al. Assessing non-cancer-related health status of us cancer patients: other-cause survival and comorbidity prevalence. Am J Epidemiol. 2013;178(3):339–49.CrossRefPubMedPubMedCentral
3.
go back to reference Miller KD, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.CrossRefPubMed Miller KD, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.CrossRefPubMed
4.
go back to reference Hoopes M, et al. Identifying and characterizing cancer survivors in the US primary care safety net. Cancer. 2019;125(19):3448–56.CrossRefPubMed Hoopes M, et al. Identifying and characterizing cancer survivors in the US primary care safety net. Cancer. 2019;125(19):3448–56.CrossRefPubMed
5.
go back to reference Williams MS et al. The association between hypertension and race/ethnicity among breast cancer survivors. J Racial Ethn Health Disparities. 2020;7(6):1172–1177 Williams MS et al. The association between hypertension and race/ethnicity among breast cancer survivors. J Racial Ethn Health Disparities. 2020;7(6):1172–1177
6.
go back to reference Tammemagi CM, et al. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294(14):1765–72.CrossRefPubMed Tammemagi CM, et al. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294(14):1765–72.CrossRefPubMed
7.
8.
go back to reference Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66(4):337–50.CrossRefPubMed Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66(4):337–50.CrossRefPubMed
9.
go back to reference SpringerLink (Online service) and Patricia A. Ganz. Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing : Imprint: Springer, 2015. SpringerLink (Online service) and Patricia A. Ganz. Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing : Imprint: Springer, 2015.
10.
go back to reference Hong C-C, Ambrosone CB, Goodwin PJ. Comorbidities and their management: potential impact on breast cancer outcomes. In: Improving Outcomes for Breast Cancer Survivors. Springer; 2015. p. 155–75.CrossRef Hong C-C, Ambrosone CB, Goodwin PJ. Comorbidities and their management: potential impact on breast cancer outcomes. In: Improving Outcomes for Breast Cancer Survivors. Springer; 2015. p. 155–75.CrossRef
11.
go back to reference Pettit S, et al. Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis. PLoS One. 2017;12(5):e0176941.CrossRefPubMedPubMedCentral Pettit S, et al. Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis. PLoS One. 2017;12(5):e0176941.CrossRefPubMedPubMedCentral
12.
go back to reference Yuan C, et al. Preexisting type 2 diabetes and survival among patients with colorectal cancer. Cancer Epidemiol Biomark Prev. 2021;30(4):757.CrossRef Yuan C, et al. Preexisting type 2 diabetes and survival among patients with colorectal cancer. Cancer Epidemiol Biomark Prev. 2021;30(4):757.CrossRef
13.
go back to reference Starfield B. Primary care: Concept, evaluation, and policy. New York: Oxford University Press; 1992. Starfield B. Primary care: Concept, evaluation, and policy. New York: Oxford University Press; 1992.
14.
go back to reference National Academies of Sciences, Engineering, and Medicine. 2021. Implementing High-Quality Primary Care: Rebuilding the Foundation of Health Care. Washington, DC: The National Academies Press. https://doi.org/10.17226/25983. National Academies of Sciences, Engineering, and Medicine. 2021. Implementing High-Quality Primary Care: Rebuilding the Foundation of Health Care. Washington, DC: The National Academies Press. https://​doi.​org/​10.​17226/​25983.
15.
go back to reference Lafata JE, et al. Preventive care receipt and office visit use among breast and colorectal cancer survivors relative to age- and gender-matched cancer-free controls. J Cancer Surviv. 2015;9(2):201–7.CrossRefPubMed Lafata JE, et al. Preventive care receipt and office visit use among breast and colorectal cancer survivors relative to age- and gender-matched cancer-free controls. J Cancer Surviv. 2015;9(2):201–7.CrossRefPubMed
16.
go back to reference Martin JY, et al. Racial disparities in the utilization of preventive health services among older women with early-stage endometrial cancer enrolled in Medicare. Cancer Med. 2017;6(9):2153–63.CrossRefPubMedPubMedCentral Martin JY, et al. Racial disparities in the utilization of preventive health services among older women with early-stage endometrial cancer enrolled in Medicare. Cancer Med. 2017;6(9):2153–63.CrossRefPubMedPubMedCentral
17.
go back to reference Wallner LP, et al. Ten-year trends in preventive service use before and after prostate cancer diagnosis: a comparison with noncancer controls. Perm J. 2017;21:16–184.CrossRefPubMedPubMedCentral Wallner LP, et al. Ten-year trends in preventive service use before and after prostate cancer diagnosis: a comparison with noncancer controls. Perm J. 2017;21:16–184.CrossRefPubMedPubMedCentral
18.
go back to reference Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101(8):1712–9.CrossRefPubMed Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101(8):1712–9.CrossRefPubMed
19.
go back to reference Finley CR, et al. What are the most common conditions in primary care? Systematic review. 2018;64(11):832–40. Finley CR, et al. What are the most common conditions in primary care? Systematic review. 2018;64(11):832–40.
21.
23.
go back to reference Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
24.
go back to reference Pruitt SL, et al. Cervical cancer burden and opportunities for prevention in a safety-net healthcare system. Cancer Epidemiol Biomarkers Prev. 2018;27(12):1398–406. Pruitt SL, et al. Cervical cancer burden and opportunities for prevention in a safety-net healthcare system. Cancer Epidemiol Biomarkers Prev. 2018;27(12):1398–406.
26.
go back to reference Craddock Lee SJ, et al. Achieving coordinated care for patients with complex cases of cancer: a multiteam system approach. J Oncol Pract. 2016;12(11):1029–38.CrossRef Craddock Lee SJ, et al. Achieving coordinated care for patients with complex cases of cancer: a multiteam system approach. J Oncol Pract. 2016;12(11):1029–38.CrossRef
27.
go back to reference Balasubramanian BA et al. Surveillance for colorectal cancer survivors in an integrated safety-net health system in the United States. Int J Care Coord. 2018;21(1-2):26–35. Balasubramanian BA et al. Surveillance for colorectal cancer survivors in an integrated safety-net health system in the United States. Int J Care Coord. 2018;21(1-2):26–35.
28.
go back to reference Balsubramanian BA et al. Thematic analyses of challenges of care coordination for underinsured and uninsured cancer survivors with chronic conditions. JAMA Netw Open. 2021;4(8):e2119080. Balsubramanian BA et al. Thematic analyses of challenges of care coordination for underinsured and uninsured cancer survivors with chronic conditions. JAMA Netw Open. 2021;4(8):e2119080.
29.
go back to reference George A, Rubin G. Non-attendance in general practice: a systematic review and its implications for access to primary health care. Fam Pract. 2003;20(2):178–84.CrossRefPubMed George A, Rubin G. Non-attendance in general practice: a systematic review and its implications for access to primary health care. Fam Pract. 2003;20(2):178–84.CrossRefPubMed
30.
go back to reference Kaplan-Lewis E, Percac-Lima S. No-show to primary care appointments: why patients do not come. J Prim Care Community Health. 2013;4(4):251–5.CrossRefPubMed Kaplan-Lewis E, Percac-Lima S. No-show to primary care appointments: why patients do not come. J Prim Care Community Health. 2013;4(4):251–5.CrossRefPubMed
31.
go back to reference Shimotsu S, et al. Increased likelihood of missed appointments (“no shows”) for racial/ethnic minorities in a safety net health system. J Prim Care Community Health. 2016;7(1):38–40.CrossRefPubMed Shimotsu S, et al. Increased likelihood of missed appointments (“no shows”) for racial/ethnic minorities in a safety net health system. J Prim Care Community Health. 2016;7(1):38–40.CrossRefPubMed
33.
go back to reference Nekhlyudov L, O’Malley DM, Hudson SV. Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities. Lancet Oncol. 2017;18(1):e30–8.CrossRefPubMedPubMedCentral Nekhlyudov L, O’Malley DM, Hudson SV. Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities. Lancet Oncol. 2017;18(1):e30–8.CrossRefPubMedPubMedCentral
35.
go back to reference Doose M, et al. Comorbidity management in black women diagnosed with breast cancer: the role of primary care in shared care. J Gen Intern Med. 2021;36(1):138–46.CrossRefPubMed Doose M, et al. Comorbidity management in black women diagnosed with breast cancer: the role of primary care in shared care. J Gen Intern Med. 2021;36(1):138–46.CrossRefPubMed
36.
37.
go back to reference Lee SJ, et al. Achieving coordinated care for patients with complex cases of cancer: a multiteam system approach. J Oncol Pract. 2016;12(11):1029–38.CrossRefPubMedPubMedCentral Lee SJ, et al. Achieving coordinated care for patients with complex cases of cancer: a multiteam system approach. J Oncol Pract. 2016;12(11):1029–38.CrossRefPubMedPubMedCentral
38.
39.
go back to reference Lemieux-Charles L, McGuire WL. What do we know about health care team effectiveness? A review of the literature. Med Care Res Rev. 2006;63(3):263–300.CrossRefPubMed Lemieux-Charles L, McGuire WL. What do we know about health care team effectiveness? A review of the literature. Med Care Res Rev. 2006;63(3):263–300.CrossRefPubMed
42.
43.
go back to reference O’Malley D, et al. Learning the landscape: implementation challenges of primary care innovators around cancer survivorship care. J Cancer Surviv. 2017;11(1):13–23.CrossRefPubMed O’Malley D, et al. Learning the landscape: implementation challenges of primary care innovators around cancer survivorship care. J Cancer Surviv. 2017;11(1):13–23.CrossRefPubMed
44.
go back to reference Parsons SK, et al. Promoting high-quality cancer care and equity through disciplinary diversity in team composition. J Oncol Pract. 2016;12(11):1141–7.CrossRefPubMed Parsons SK, et al. Promoting high-quality cancer care and equity through disciplinary diversity in team composition. J Oncol Pract. 2016;12(11):1141–7.CrossRefPubMed
Metadata
Title
Importance of primary care for underserved cancer patients with multiple chronic conditions
Authors
Katelyn K. Jetelina
Simon Craddock Lee
Quiera S. Booker-Nubie
Udoka C. Obinwa
Hong Zhu
Michael E. Miller
Navid Sadeghi
Umber Dickerson
Bijal A. Balasubramanian
Publication date
05-01-2022
Publisher
Springer US
Keyword
Care
Published in
Journal of Cancer Survivorship / Issue 5/2023
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01159-8

Other articles of this Issue 5/2023

Journal of Cancer Survivorship 5/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine